- Home
- SLQT vs HUMA Comparison
SLQT vs HUMA Comparison
Compare SLQT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- HUMA
- Stock Information
- Founded
- SLQT 1999
- HUMA 2004
- Country
- SLQT United States
- HUMA United States
- Employees
- SLQT N/A
- HUMA N/A
- Industry
- SLQT Specialty Insurers
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- HUMA Health Care
- Exchange
- SLQT Nasdaq
- HUMA Nasdaq
- Market Cap
- SLQT 386.9M
- HUMA 367.6M
- IPO Year
- SLQT 2020
- HUMA N/A
- Fundamental
- Price
- SLQT $2.26
- HUMA $2.35
- Analyst Decision
- SLQT Hold
- HUMA Strong Buy
- Analyst Count
- SLQT 2
- HUMA 7
- Target Price
- SLQT $3.38
- HUMA $13.00
- AVG Volume (30 Days)
- SLQT 987.5K
- HUMA 3.4M
- Earning Date
- SLQT 05-12-2025
- HUMA 08-12-2025
- Dividend Yield
- SLQT N/A
- HUMA N/A
- EPS Growth
- SLQT N/A
- HUMA N/A
- EPS
- SLQT N/A
- HUMA N/A
- Revenue
- SLQT $1,488,701,000.00
- HUMA $517,000.00
- Revenue This Year
- SLQT $17.72
- HUMA N/A
- Revenue Next Year
- SLQT $13.05
- HUMA $896.45
- P/E Ratio
- SLQT N/A
- HUMA N/A
- Revenue Growth
- SLQT 20.41
- HUMA N/A
- 52 Week Low
- SLQT $1.62
- HUMA $1.15
- 52 Week High
- SLQT $6.86
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- SLQT 46.15
- HUMA 53.81
- Support Level
- SLQT $2.30
- HUMA $2.25
- Resistance Level
- SLQT $2.69
- HUMA $2.57
- Average True Range (ATR)
- SLQT 0.12
- HUMA 0.19
- MACD
- SLQT 0.00
- HUMA 0.01
- Stochastic Oscillator
- SLQT 12.64
- HUMA 49.65
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.